DVA
Q4 2026 EPS Estimate
$3.78
Oct 28, 2026 · Reports after close
Revenue Estimate
$3.51B
FY2026E EPS$14.79
FY2027E EPS$17.01

Analyst Sentiment

Wall St. Consensus
Hold
22 analysts·High coverage
59
Score
9 Buy (41%)12 Hold (55%)1 Sell (4%)
Rating Breakdown
Strong Buy
00%
Buy
941%
Hold
1255%
Sell
15%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$215.00
+18.6%
Consensus
$222.00
+22.5%
Bull
$270.00
+48.9%
12-Month Target Range22 analysts
$215.00$222.00$270.00
Current $181.29Consensus
Current Price
$181.29
Upside to Consensus
$40.71

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+2.80%
EPS+14.98%
FY2028
Rev+0.18%
EPS+13.07%
FY2029
Rev+9.61%
EPS-5.80%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029E
Revenue Avg$14.08B$14.47B$14.50B$15.89B
Low$13.92B$14.24B$13.89B$15.56B
High$14.28B$14.88B$15.31B$16.43B
EBITDA Avg$2.78B$2.86B$2.87B$3.14B
Low$2.75B$2.81B$2.75B$3.08B
High$2.82B$2.94B$3.03B$3.25B
EBIT Avg$1.96B$2.02B$2.02B$2.21B
Low$1.94B$1.98B$1.93B$2.17B
High$1.99B$2.07B$2.13B$2.29B
Net Income Avg$1.31B$1.50B$1.69B$1.60B
Low$1.25B$1.41B$1.61B$1.55B
High$1.38B$1.59B$1.77B$1.67B
EPS Avg$14.79$17.01$19.23$18.12
Low$14.18$16.02$18.32$17.63
High$15.66$18.05$20.14$18.91
Analysts (Rev / EPS)5 / 45 / 53 / 21 / 1
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027
Revenue Avg$3.51B$3.62B$3.51B$3.61B$3.63B$3.67B
Low$3.48B$3.58B$3.48B$3.58B$3.60B$3.63B
High$3.54B$3.65B$3.54B$3.64B$3.66B$3.70B
EBITDA Avg$694M$715M$694M$714M$718M$725M
Low$687M$708M$687M$707M$711M$718M
High$699M$721M$699M$719M$723M$731M
EBIT Avg$489M$504M$489M$503M$506M$511M
Low$484M$499M$484M$498M$501M$506M
High$493M$508M$493M$507M$510M$515M
Net Income Avg$244M$286M$227M$297M$264M$330M
Low$241M$282M$224M$294M$261M$326M
High$246M$289M$229M$300M$267M$333M
EPS Avg$3.68$4.32$3.44$4.50$3.99$4.99
Low$3.64$4.27$3.39$4.44$3.94$4.93
High$3.72$4.37$3.47$4.54$4.03$5.04
Analysts (Rev / EPS)3 / 33 / 31 / 11 / 11 / 11 / 1

Earnings Surprises

Recent Analyst Actions

Aug 7, 2026Truist Financial
DaVita price target lowered to $215 from $250 at Truist
Target:$215.00
+19.5%from $179.93
Aug 7, 2026Oppenheimer
TD Cowen Upgrades DaVita (DVA) to Buy
Target:$220.00
+21.8%from $180.67
Aug 7, 2026Raymond James
TD Cowen Upgrades DaVita (DVA) to Buy
Target:$220.00
+21.8%from $180.67
Aug 5, 2026Deutsche Bank
DaVita price target raised to $265 from $220 at Deutsche Bank
Target:$265.00
+42.8%from $185.53
Aug 5, 2026Barclays
DaVita price target raised to $224 from $218 at Barclays
Target:$224.00
-1.8%from $227.99
Jul 14, 2026Truist Financial
DaVita price target raised to $250 from $205 at Truist
Target:$250.00
+6.1%from $235.58
Jul 10, 2026UBS
DaVita price target raised to $270 from $235 at UBS
Target:$270.00
+17.7%from $229.48
Jul 8, 2026Barclays
DaVita price target raised to $218 from $194 at Barclays
Target:$218.00
-7.0%from $234.31
May 8, 2026Truist Financial
DaVita price target raised to $205 from $158 at Truist
Target:$205.00
+5.5%from $194.38
May 7, 2026Barclays
DaVita price target raised to $194 from $158 at Barclays
Target:$194.00
+0.1%from $193.88
May 6, 2026Deutsche Bank
DaVita upgraded to Buy from Hold at Deutsche Bank
Target:$220.00
+40.1%from $157.04
Feb 5, 2026Truist Financial
DaVita price target raised to $158 from $128 at Truist
Target:$158.00
+9.4%from $144.41
Feb 4, 2026UBS
DaVita price target raised to $190 from $186 at UBS
Target:$190.00
+41.0%from $134.73
Feb 3, 2026Barclays
DaVita price target raised to $158 from $143 at Barclays
Target:$158.00
+42.1%from $111.19
Oct 30, 2025Barclays
DaVita price target lowered to $143 from $149 at Barclays
Target:$143.00
+13.0%from $126.56
Oct 14, 2025Truist Financial
DaVita price target lowered to $140 from $148 at Truist
Target:$140.00
+13.5%from $123.36
Oct 9, 2025Barclays
DaVita price target lowered to $149 from $160 at Barclays
Target:$149.00
+16.5%from $127.89
Aug 8, 2025Truist Financial
DaVita price target lowered to $148 from $164 at Truist
Target:$148.00
+14.3%from $129.54
Feb 21, 2025Bernstein
Warren Buffett's Berkshire Hathaway Sells $116M Shares Of Dialysis Giant DaVita, Cuts Stake By 2%
Target:$184.00
+29.2%from $142.40
Aug 7, 2024Bank of America Securities
DaVita price target raised to $145 from $139 at BofA
Target:$145.00
+8.6%from $133.53
May 6, 2024Barclays
DaVita price target raised to $150 from $133 at Barclays
Target:$150.00
+11.6%from $134.45
Oct 31, 2022Barclays
DaVita price target lowered to $81 from $103 at Barclays
Target:$81.00
+14.8%from $70.54
Aug 19, 2022UBS
UBS Assumes DaVita (DVA) with a Buy
Target:$117.00
+25.7%from $93.10
Jun 28, 2022Truist Financial
DaVita (DVA) Stock: $90 Target And Hold Rating
Target:$90.00
+13.3%from $79.44
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.